MoneyWorks4Me

Mercury Laboratories - Quaterly Results

05 May 2023 Evaluate
A decent increase of about 45.74% in the sales to Rs. 194.31 millions was observed for the quarter ended March 2023. The sales figure stood at Rs. 133.33 millions during the year-ago period.Net Profit of the company move down -55.68% to Rs. 3.67  millions from Rs. 8.28 millions  in the same quarter last year.A decline of 14.70 millions was observed in the OP in the quarter ended March 2023 from 17.52 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 194.31 133.33 45.74 753.34 579.24 30.06 753.34 579.24 30.06
Other Income 4.27 5.69 -24.96 17.19 8.16 110.66 17.19 8.16 110.66
PBIDT 14.70 17.52 -16.10 102.90 78.06 31.82 102.90 78.06 31.82
Interest 0.98 0.40 145.00 3.62 4.46 -18.83 3.62 4.46 -18.83
PBDT 14.20 17.12 -17.06 99.76 74.88 33.23 99.76 74.88 33.23
Depreciation 6.19 6.17 0.32 24.83 24.53 1.22 24.83 24.53 1.22
PBT 8.01 10.95 -26.85 74.93 50.35 48.82 74.93 50.35 48.82
TAX 4.34 2.67 62.55 19.14 14.73 29.94 19.14 14.73 29.94
Deferred Tax -0.08 -0.55 -85.45 -3.38 1.02 -431.37 -3.38 1.02 -431.37
PAT 3.67 8.28 -55.68 55.79 35.62 56.63 55.79 35.62 56.63
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 7.57 13.14 -42.43 13.66 13.48 1.36 13.66 13.48 1.36
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1244.50
Cipla 1384.85
Lupin 2076.00
Zydus Lifesciences 1214.25
View more..